Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062367
  • May 2021
  • Medical Devices
  • 134 Pages
The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered B. Braun Melsungen AG, Medtronic PLC, Abbott Inc., Boston Scientific Corporation, Biotronik Se and Co.KG, Spectranetics Corporation, Cordis Corporation, ENDOCOR GmbH, CR Bard Inc, Terumo Corporation
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market is expected to attain Pre COVID-19 levels by mid-2022.

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Competitive and Premeditated Analysis
In the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market:
The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. B. Braun Melsungen AG, Medtronic PLC, Abbott Inc., Boston Scientific Corporation, Biotronik Se and Co.KG, Spectranetics Corporation, Cordis Corporation, ENDOCOR GmbH, CR Bard Inc, Terumo Corporation

The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market:
By Type
Paclitaxel-eluting Type
Others
End-Users
Hospitals
Clinics
Others

Regional Analysis of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market:
The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • B. Braun Melsungen AG
  • Medtronic PLC
  • Abbott Inc.
  • Boston Scientific Corporation
  • Biotronik Se and Co.KG
  • Spectranetics Corporation
  • Cordis Corporation
  • ENDOCOR GmbH
  • CR Bard Inc
  • Terumo Corporation
  • Paclitaxel-eluting Type
  • Others
  • Hospitals
  • Clinics
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Snapshot
          2.1.1. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market By Type,2019
               2.1.1.1.Paclitaxel-eluting Type
               2.1.1.2.Others
          2.1.2. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market By End-Users,2019
               2.1.2.1.Hospitals
               2.1.2.2.Clinics
               2.1.2.3.Others
          2.1.3. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market By End-use,2019
          2.1.4. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market By Geography,2019

3. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Type, 2018 – 2028

5. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-Users, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End-Users, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End-Users, 2020
     5.2. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-Users, 2018 – 2028

6. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-use, 2018 – 2028

7. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Analysis, 2018 – 2028 
          7.2.1. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-Users, 2018 – 2028
          7.2.4. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Analysis, 2018 – 2028 
          7.3.1.  Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-Users, 2018 – 2028
          7.3.4. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-Users, 2018 – 2028
          7.4.4. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-Users, 2018 – 2028
          7.5.4. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Analysis, 2018 – 2028 
          7.6.1.  MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-Users, 2018 – 2028
          7.6.4. MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Providers
        8.4.1 B. Braun Melsungen AG
                8.4.1.1 Business Description
                8.4.1.2 B. Braun Melsungen AG Geographic Operations
                8.4.1.3 B. Braun Melsungen AG Financial Information
                8.4.1.4 B. Braun Melsungen AG Product Positions/Portfolio
                8.4.1.5 B. Braun Melsungen AG Key Developments
        8.4.2 Medtronic PLC
                8.4.2.1 Business Description
                8.4.2.2 Medtronic PLC Geographic Operations
                8.4.2.3 Medtronic PLC Financial Information
                8.4.2.4 Medtronic PLC Product Positions/Portfolio
                8.4.2.5 Medtronic PLC Key Developments
        8.4.3 Abbott Inc.
                8.4.3.1 Business Description
                8.4.3.2 Abbott Inc. Geographic Operations
                8.4.3.3 Abbott Inc. Financial Information
                8.4.3.4 Abbott Inc. Product Positions/Portfolio
                8.4.3.5 Abbott Inc. Key Developments
        8.4.4 Boston Scientific Corporation
                8.4.4.1 Business Description
                8.4.4.2 Boston Scientific Corporation Geographic Operations
                8.4.4.3 Boston Scientific Corporation Financial Information
                8.4.4.4 Boston Scientific Corporation Product Positions/Portfolio
                8.4.4.5 Boston Scientific Corporation Key Developments
        8.4.5 Biotronik Se and Co.KG
                8.4.5.1 Business Description
                8.4.5.2 Biotronik Se and Co.KG Geographic Operations
                8.4.5.3 Biotronik Se and Co.KG Financial Information
                8.4.5.4 Biotronik Se and Co.KG Product Positions/Portfolio
                8.4.5.5 Biotronik Se and Co.KG Key Developments
        8.4.6 Spectranetics Corporation
                8.4.6.1 Business Description
                8.4.6.2 Spectranetics Corporation Geographic Operations
                8.4.6.3 Spectranetics Corporation Financial Information
                8.4.6.4 Spectranetics Corporation Product Positions/Portfolio
                8.4.6.5 Spectranetics Corporation Key Developments
        8.4.7 Cordis Corporation
                8.4.7.1 Business Description
                8.4.7.2 Cordis Corporation Geographic Operations
                8.4.7.3 Cordis Corporation Financial Information
                8.4.7.4 Cordis Corporation Product Positions/Portfolio
                8.4.7.5 Cordis Corporation Key Developments
        8.4.8 ENDOCOR GmbH
                8.4.8.1 Business Description
                8.4.8.2 ENDOCOR GmbH Geographic Operations
                8.4.8.3 ENDOCOR GmbH Financial Information
                8.4.8.4 ENDOCOR GmbH Product Positions/Portfolio
                8.4.8.5 ENDOCOR GmbH Key Developments
        8.4.9 CR Bard Inc
                8.4.9.1 Business Description
                8.4.9.2 CR Bard Inc Geographic Operations
                8.4.9.3 CR Bard Inc Financial Information
                8.4.9.4 CR Bard Inc Product Positions/Portfolio
                8.4.9.5 CR Bard Inc Key Developments
        8.4.10 Terumo Corporation
                8.4.10.1 Business Description
                8.4.10.2 Terumo Corporation Geographic Operations
                8.4.10.3 Terumo Corporation Financial Information
                8.4.10.4 Terumo Corporation Product Positions/Portfolio
                8.4.10.5 Terumo Corporation Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-Users, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-Users, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-Users, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-Users, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-Users, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters: Market Segmentation 
FIG. 2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market, By End-Users, 2019 (US$ Mn) 
FIG. 6 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Providers, 2019
FIG. 11 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue Contribution, By End-Users, 2019 & 2028 (Value %) 
FIG. 13 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment1, 2018 – 2028
TABLE  North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment2, 2018 – 2028
TABLE  North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Country, 2018 – 2028
TABLE  Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment1, 2018 – 2028
TABLE  Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment2, 2018 – 2028
TABLE  Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Country, 2018 – 2028
TABLE  Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Country, 2018 – 2028
TABLE  MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment1, 2018 – 2028
TABLE  MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Segment2, 2018 – 2028
TABLE  MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, By Country, 2018 – 2028
TABLE  B. Braun Melsungen AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Medtronic PLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boston Scientific Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biotronik Se and Co.KG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Spectranetics Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cordis Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ENDOCOR GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CR Bard Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Terumo Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market, By Geography, 2019 (US$ Mn)
FIG.  Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Providers, 2016
FIG.  Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Value, 2018 – 2028, (US$ Mn)